Shujun Li - Publications

Genomic Disruption of CAMKMT by t(2;11)(p21;q23) Reveals a Glycolytic Reprogramming Mechanism in Acute Myeloid Leukemia.

Journal: Current medicinal chemistry

Published: September 10, 2025

m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis.

Journal: Cancer research communications

Published: July 29, 2025

Subsequent risk of death from sepsis among over 6 million cancer patients: A population-based cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 21, 2025

METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression.

Journal: Journal of translational medicine

Published: December 29, 2024

New perspectives on cancer clinical research in the era of big data and machine learning.

Journal: Surgical oncology

Published: August 29, 2023

Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Published: May 30, 2023

Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1.

Journal: Scientific reports

Published: February 16, 2023

LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.

Journal: Cytokine

Published: July 18, 2022